PDB Short entry for 1AZG HEADER COMPLEX (PHOSPHOTRANSFERASE/PEPTIDE) 18-NOV-97 1AZG TITLE NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE TITLE 2 KINASE COMPLEXED WITH THE SYNTHETIC PEPTIDE P2L CORRESPONDING TO TITLE 3 RESIDUES 91-104 OF THE P85 SUBUNIT OF PI3-KINASE, MINIMIZED AVERAGE TITLE 4 (PROBMAP) STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PRO-PRO-ARG-PRO-LEU-PRO-VAL-ALA-PRO-GLY-SER-SER-LYS-THR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P85 SUBUNIT OF PI3-KINASE, RESIDUES 91 - 104; COMPND 5 SYNONYM: P2L; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: FYN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: SH3 DOMAIN, RESIDUES 82 - 148; COMPND 11 EC: 2.7.1.112; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 MOL_ID: 2; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 CELL_LINE: BL21; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX KEYWDS COMPLEX (PHOSPHOTRANSFERASE-PEPTIDE), SH3 DOMAIN, POLYPROLINE- KEYWDS 2 BINDING, PHOSPHOTRANSFERASE, COMPLEX (PHOSPHOTRANSFERASE-PEPTIDE) KEYWDS 3 COMPLEX EXPDTA SOLUTION NMR AUTHOR D.A.RENZONI,D.J.R.PUGH,G.SILIGARDI,P.DAS,C.J.MORTON,C.ROSSI, AUTHOR 2 M.D.WATERFIELD,I.D.CAMPBELL,J.E.LADBURY REVDAT 3 16-FEB-22 1AZG 1 REMARK REVDAT 2 24-FEB-09 1AZG 1 VERSN REVDAT 1 25-FEB-98 1AZG 0 JRNL AUTH D.A.RENZONI,D.J.PUGH,G.SILIGARDI,P.DAS,C.J.MORTON,C.ROSSI, JRNL AUTH 2 M.D.WATERFIELD,I.D.CAMPBELL,J.E.LADBURY JRNL TITL STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE JRNL TITL 2 INTERACTION OF THE SH3 DOMAIN FROM FYN WITH THE PROLINE-RICH JRNL TITL 3 BINDING SITE ON THE P85 SUBUNIT OF PI3-KINASE. JRNL REF BIOCHEMISTRY V. 35 15646 1996 JRNL REFN ISSN 0006-2960 JRNL PMID 8961927 JRNL DOI 10.1021/BI9620969 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.J.MORTON,D.J.PUGH,E.L.BROWN,J.D.KAHMANN,D.A.RENZONI, REMARK 1 AUTH 2 I.D.CAMPBELL REMARK 1 TITL SOLUTION STRUCTURE AND PEPTIDE BINDING OF THE SH3 DOMAIN REMARK 1 TITL 2 FROM HUMAN FYN REMARK 1 REF STRUCTURE V. 4 705 1996 REMARK 1 REFN ISSN 0969-2126 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE. REMARK 4 REMARK 4 1AZG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171443. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 RES C SSSEQI REMARK 465 THR B 82 REMARK 465 GLY B 83 REMARK 465 ASP B 142 REMARK 465 SER B 143 REMARK 465 ILE B 144 REMARK 465 GLN B 145 REMARK 465 ALA B 146 REMARK 465 GLU B 147 REMARK 465 GLU B 148 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 95 98.40 67.31 REMARK 500 PRO A 96 98.10 -61.17 REMARK 500 ALA A 98 173.05 -47.51 REMARK 500 PRO A 99 83.30 -60.78 REMARK 500 THR B 85 71.58 -152.64 REMARK 500 ALA B 95 106.10 -56.28 REMARK 500 ASP B 100 -176.51 -64.57 REMARK 500 PHE B 103 -172.34 -174.58 REMARK 500 GLU B 116 -153.36 -57.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 93 0.29 SIDE CHAIN REMARK 500 ARG B 123 0.13 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 1AZG A 91 104 UNP P27986 P85A_HUMAN 91 104 DBREF 1AZG B 82 148 UNP P06241 FYN_HUMAN 81 147 SEQRES 1 A 14 PRO PRO ARG PRO LEU PRO VAL ALA PRO GLY SER SER LYS SEQRES 2 A 14 THR SEQRES 1 B 67 THR GLY VAL THR LEU PHE VAL ALA LEU TYR ASP TYR GLU SEQRES 2 B 67 ALA ARG THR GLU ASP ASP LEU SER PHE HIS LYS GLY GLU SEQRES 3 B 67 LYS PHE GLN ILE LEU ASN SER SER GLU GLY ASP TRP TRP SEQRES 4 B 67 GLU ALA ARG SER LEU THR THR GLY GLU THR GLY TYR ILE SEQRES 5 B 67 PRO SER ASN TYR VAL ALA PRO VAL ASP SER ILE GLN ALA SEQRES 6 B 67 GLU GLU HELIX 1 HA PRO B 134 TYR B 137 5 4 SHEET 1 S1 3 LYS B 108 LEU B 112 0 SHEET 2 S1 3 LEU B 86 ALA B 89 -1 N PHE B 87 O PHE B 109 SHEET 3 S1 3 VAL B 138 PRO B 140 -1 O ALA B 139 N VAL B 88 SHEET 1 S2 3 ASN B 113 SER B 114 0 SHEET 2 S2 3 TRP B 119 SER B 124 -1 N GLU B 121 O ASN B 113 SHEET 3 S2 3 THR B 130 ILE B 133 -1 O ILE B 133 N TRP B 120 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000